Background: Omicron (B.1.1.529), a variant of SARS-CoV-2 is currently spreading globally as a dominant strain. Due to multiple mutations at its Spike protein, including 15 amino acid substitutions at the receptor binding domain (RBD), Omicron is a variant of concern (VOC) and capable of escaping vaccine generated immunity. So far, no specific treatment regime is suggested for this VOC. Methods: The three-dimensional structure of the Spike RBD domain of Omicron variant was constructed by incorporating 15 amino acid substitutions to the Native Spike (S) structure and structural changes were compared that of the Native S. Seven phytochemicals namely Allicin, Capsaicin, Cinnamaldehyde, Curcumin, Gingerol, Piperine, and Zingeberene were docked with Omicron S protein and Omicron S-hACE2 complex. Further, molecular dynamic simulation was performed between Crcumin and Omicron S protein to evaluate the structural stability of the complex in the physiological environment and compared with that of the control drug Chloroquine. Results: Curcumin, among seven phytochemicals, was found to have the most substantial inhibitory potential with Omicron S protein. Further, it was found that curcumin could disrupt the Omicron S-hACE2 complex. The molecular dynamic simulation demonstrated that Curcumin could form a stable structure with Omicron S in the physiological environment. Conclusion: To conclude, Curcumin can be considered as a potential therapeutic agent against the highly infectious Omicron variant of SARS-CoV-2.

Author contributions A.N. conceived, designed the study & performed the experimentations; Primary data analysis & manuscript draft preparation were done by S.P. Secondary data analysis was done by RB and proof reading & manuscript finalisation was done by R.K. All authors read and approved the final manuscript. Declaration of competing interest Authors declare that there is no conflict of interest. Appendix A. Supplementary data Supplementary data to this article can be found online at https://doi. org/10.1016/j.compbiomed.2022.105552.

References

Aliebrahimi, Montasser, Kouhsari, Ostad, Arab et al., Identification of phytochemicals targeting c-met kinase domain using consensus docking and molecular dynamics simulation studies, Cell Biochem. Biophys, doi:10.1007/s12013-017-0821-6

Choudhary, Malik, Tomar, Identification of SARS-CoV-2 cell entry inhibitors by drug repurposing using in silico structure-based virtual screening approach, Front. Immunol

Cs De Magalhães, Almeida, Barbosa, Dardenne, A dynamic niching genetic algorithm strategy for docking highly flexible ligands, Inf. Sci, doi:10.1016/j.ins.2014.08.002

Dedecker, O'brien, Fleming, Geiger, Jackson et al., The crystal structure of a hyperthermophilic archaeal TATA-box binding protein, J. Mol. Biol, doi:10.1006/jmbi.1996.0697

Desta, Porter, Xia, Kozakov, Vajda, Performance and its limits in rigid body protein-protein docking, Structure, doi:10.1016/j.str.2020.06.006

Dolgin, Omicron thwarts some of the world's most-used COVID vaccines, Nature

Du, Qian, Xue, Molecular simulation of oncostatin M and receptor (OSM-OSMR) interaction as a potential therapeutic target for inflammatory bowel disease, Front. Mol. Biosci

Fu, Tu, Ping, Zheng, Yang et al., Subtype-selective mechanisms of negative allosteric modulators binding to group I metabotropic glutamate receptors, Acta Pharmacol. Sin, doi:10.1038/s41401-020-00541-z

Greaney, Starr, Bloom, An antibody-escape calculator for mutations to the SARS-CoV-2 receptor-binding domain, bioRxiv, doi:10.1101/2021.12.04.471236

Gupta, Vemula, Donde, Gouda, Behera et al., In-silico approaches to detect inhibitors of the human severe acute respiratory syndrome coronavirus envelope protein ion channel, J. Biomol. Struct. Dyn, doi:10.1080/07391102.2020.1751300

Harvey, Carabelli, Jackson, Gupta, Thomson et al., SARS-CoV-2 variants, spike mutations and immune escape, Nat. Rev. Microbiol, doi:10.1038/s41579-021-00573-0

He, Hong, Pan, Lu, Wei, SARS-CoV-2 Omicron variant: characteristics and prevention, MedComm, doi:10.1002/mco2.110

Jena, Kanungo, Nayak, Chainy Gbn, Dandapat, Catechin and curcumin interact with S protein of SARS-CoV2 and ACE2 of human cell membrane: insights from computational studies, Sci. Rep, doi:10.1038/s41598-021-81462-7

Korber, Fischer, Gnanakaran, Yoon, Theiler et al., Tracking changes in SARS-CoV-2 spike: evidence that D614G increases infectivity of the COVID-19 virus, Cell, doi:10.1016/j.cell.2020.06.043

Kumari, Kumar, Open Source Drug Discovery Consortium, A. Lynn, g_ mmpbsa-a GROMACS tool for high-throughput MM-PBSA calculations, J. Chem. Inf. Model, doi:10.1021/ci500020m

Kushwaha, Singh, Prajapati, Shuaib, Gupta et al., Phytochemicals present in Indian ginseng possess potential to inhibit SARS-CoV-2 virulence: a molecular docking and MD simulation study, Microb. Pathog, doi:10.1016/j.micpath.2021.104954

Kutzner, Páll, Fechner, Esztermann, De Groot et al., More bang for your buck: improved use of GPU nodes for GROMACS 2018, J. Comput. Chem, doi:10.1002/jcc.26011

Li, Li, Hong, Wang, Fu et al., Clinical trials, progression-speed differentiating features and swiftness rule of the innovative targets of first-in-class drugs, Briefings Bioinf, doi:10.1093/bib/bby130

Li, Nie, Wu, Zhang, Ding et al., SARS-CoV-2 501Y.V2 variants lack higher infectivity but do have immune escape, Cell, doi:10.1016/j.cell.2021.02.042

Liu, Vanblargan, Bloyet, Rothlauf, Chen et al., Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization, Cell Host Microbe, doi:10.1016/j.chom.2021.01.014

Marín-Palma, Tabares-Guevara, Zapata-Cardona, Flórez-Álvarez, Yepes et al., Curcumin inhibits in vitro SARS-CoV-2 infection in Vero E6 cells through multiple antiviral mechanisms, Molecules, doi:10.3390/molecules26226900

Nag, Banerjee, Chowdhury, Venkatesh, Phytochemicals as potential drug candidates for targeting SARS CoV 2 proteins, an in silico study, Virus. Dis, doi:10.1007/s13337-021-00654-x

Nag, Paul, Banerjee, Kundu, In silico study of some selective phytochemicals against a hypothetical SARS-CoV-2 spike RBD using molecular docking tools, Comput. Biol. Med, doi:10.1016/j.compbiomed.2021.104818

Pandurangan, Ochoa-Montaño, Ascher, Blundell, SDM: a server for predicting effects of mutations on protein stability, Nucleic Acids Res, doi:10.1093/nar/gkx439

Rao, Shetty, Evolutionary selectivity of amino acid is inspired from the enhanced structural stability and flexibility of the folded protein, Life Sci, doi:10.1016/j.lfs.2021.119774

Ren, Wang, Gao, Zhou, Omicron variant (B.1.1.529) of SARS-CoV-2: mutation, infectivity, transmission, and vaccine resistance, World J Clin Cases, doi:10.12998/wjcc.v10.i1.1

Ribaudo, Coghi, Yang, Ng, Mastinu et al., Computational and experimental insights on the interaction of artemisinin, dihydroartemisinin and chloroquine with SARS-CoV-2 spike protein receptorbinding domain (RBD), Nat. Prod. Res, doi:10.1080/14786419.2021.1925894

Richards, Lim, An analysis of packing in the protein folding problem, Q. Rev. Biophys, doi:10.1017/s0033583500002845

Schüttelkopf, Van Aalten, PRODRG: a tool for high-throughput crystallography of protein-ligand complexes, Acta Crystallogr. Sect. D Biol. Crystallogr, doi:10.1107/S0907444904011679

Singh, Chauhan, Pandit, Sinha, Gupta et al., The dual role of phytochemicals on SARS-CoV-2 inhibition by targeting host and viral proteins, Complementary Altern. Med, doi:10.1016/j.jtcme.2021.09.001

Tong, Shi, Zhang, Shi, Tracking and controlling the spatiotemporal spread of SARS-CoV-2 Omicron variant in South Africa, Trav. Med. Infect. Dis, doi:10.1016/j.tmaid.2021.102252

Wang, Schmidt, Weisblum, Muecksch, Barnes et al., mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants, Nature, doi:10.1038/s41586-021-03324-6

Xue, Wang, Tu, Yang, Zheng et al., Computational identification of the binding mechanism of a triple reuptake inhibitor amitifadine for the treatment of major depressive disorder, Phys. Chem. Chem. Phys, doi:10.1039/C7CP07869B

Xue, Yang, Wang, Zheng, Chen et al., What contributes to serotonin-norepinephrine reuptake inhibitors' dual-targeting mechanism? The key role of transmembrane domain 6 in human serotonin and norepinephrine transporters revealed by molecular dynamics simulation, ACS Chem. Neurosci, doi:10.1021/acschemneuro.7b00490

Yang, Lin, Xing, Zhang, Zhang et al., Structure-based discovery of novel nonpeptide inhibitors targeting SARS-CoV-2 Mpro, J. Chem. Inf. Model, doi:10.1021/acs.jcim.1c00355

Yang, Qin, Li, Tao, Zhou et al., Therapeutic target database update 2016: enriched resource for bench to clinical drug target and targeted pathway information, Nucleic Acids Res, doi:10.1093/nar/gkv1230

Yang, Yu, Chang, Liang, Tso et al., Effect of SARS-CoV-2 B.1.1.7 mutations on spike protein structure and function, Nat. Struct. Mol. Biol, doi:10.1038/s41594-021-00652-z

Yang, Zhang, Yang, Zhang, Wu et al., Computational design and modeling of nanobodies toward SARS-CoV-2 receptor binding domain, Chem. Biol. Drug Des, doi:10.1111/cbdd.13847

Zhang, Wu, Wu, Yang, Chen et al., SARS-CoV-2 Omicron strain exhibits potent capabilities for immune evasion and viral entrance, Signal Transduct, Targeted Ther, doi:10.1038/s41392-021-00852-5

Zhu, Shi, Qin, Tao, Liu et al., Therapeutic target database update 2012: a resource for facilitating target-oriented drug discovery, Nucleic Acids Res, doi:10.1093/nar/gkr797

Download Image

Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.

Submit

@CovidAnalysis

FAQ

Public domain CC0 1.0